Incretins Show Real-World Metabolic Gains Across Care Models
In adults with T2D and obesity receiving standard diabetes care, incretin therapy lowers A1c percentage, body weight, and LDL cholesterol, regardless of weight management clinic referral.
Medscape Medical News
source https://www.medscape.com/viewarticle/incretins-show-real-world-metabolic-gains-across-care-models-2026a100022k?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/incretins-show-real-world-metabolic-gains-across-care-models-2026a100022k?src=rss
Comments
Post a Comment